Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
We support pharmaceutical firms and medical affairs sections in medical device companies in Japan, working to develop real-world evidence. We draft research design to advise on the selection of appropriate real-world data, draft forms for protocol/ethics committees, analyze data, and develop materials for academic conferences. We develop, identify, select, propose, and assess the most appropriate analytic methods for given research questions.
Through analyses of real-world data, including health insurance claims, administrative information, and electronic health records, we perform research regarding actual treatment status and medical costs, and compare outcomes of different treatment types .
Our consultants, especially those with the Certified Medical Publication Professional (CMPP) qualification, develop research papers on analyses of real-world data.
We provide comprehensive support to clients on private medical insurance, including concept planning, market studies, future projections, development of assumed rates, pricing calculations, development of filing materials, and negotiations with administrative agencies.
We broadly assist companies trying to launch new healthcare businesses, including brainstorming, feasibility studies, proof of concept, and development of business plans.
We support decision making regarding healthcare policies, such as those for regional healthcare initiatives, through the development of various health economics and assessment methodologies/quantitative evidence. This includes the development of healthcare demands in line with the actual situation in the region and optimization of healthcare resource allocations.
Using predictive models, we assess healthcare business return on investment and cost-effectiveness.
Using Milliman Hospital Performance Index (HPI), we calculate cash flows of each disease group and assist in shortening the length of hospitalization.
We will develop data-based models and reflect causal structures to make simulations for each option to assist management decisions.
Articles originally published by the National Center for Biotechnology Information and published by Milliman Insight.
We’re here to help you break through complex challenges and achieve next-level success.